Clinical trial Recruiting at 1 site Interventional Ages 40 to 85

Comparing two treatments for glaucoma with cataract

Official title: Efficacy of Phacogoniotomy in Medically-controlled Primary Open-angle Glaucoma With Cataract a Multicenter Non-inferiority Randomized Controlled Trial

Run by Sun Yat-sen University · NCT06201455 · Data updated 2026-11-12

This study is testing whether a new surgery for glaucoma combined with cataract removal works as well as the usual surgery plus eye drops for people with both conditions.

Quick facts

Study typeInterventional
Ages40 Years to 85 Years
SexAll
Enrollment100 (estimated)
SponsorSun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedSeptember 28, 2023
Main results expectedSeptember 30, 2026
Study endsDecember 31, 2029
Registry record updatedDecember 11, 2024
Trial IDNCT06201455 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 40 to 85 diagnosed with medically-controlled primary open-angle glaucoma and cataract.

Probably not a fit

Patients with a history of intraocular surgery, other types of glaucoma, or severe ocular diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized controlled trial aims to evaluate the effectiveness of phacoemulsification with goniotomy (PEI+GT) versus phacoemulsification with medical therapy (PEI+MED) in patients with medically-controlled primary open-angle glaucoma (POAG) and cataract. Participants will be randomly assigned to receive either treatment and will be followed for one year to assess intraocular pressure reduction and health economics. The study seeks to determine if the minimally invasive approach of PEI+GT is as effective as the traditional medical therapy while potentially offering benefits in terms of recovery and complications.

Why it matters

Potential benefit: If successful, this study could provide a less invasive treatment option for patients with glaucoma and cataract, reducing their reliance on medication.

How similar studies have gone: Previous studies have shown promising results for minimally invasive glaucoma surgeries, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 40 ≤ Age ≤ 85 years, gender unrestricted.
2. Diagnosed with POAG.
3. Controlled IOP under 1 to 4 topical hypotensive medications, IOP ≤ 24 mmHg
4. Mean deviation (MD) for perimetry ≥ -16dB.
5. Presence of clinically significant cataract and best-corrected visual acuity measured using the ETDRS chart ≤ 0.63.
6. Voluntary participation of the patient in this study, signing an informed consent form, and agreeing to follow-up visits according to the study protocol.

Exclusion Criteria:

1. Any history of intraocular surgery or ocular trauma.
2. Presence of other types of glaucoma, including primary angle-closure glaucoma and various forms of secondary glaucoma (e.g. secondary angle-closure, pigmentary, steroid-induced, angle-recession, neovascular, inflammatory, and pseudoexfoliation syndrome).
3. Presence of severe ocular diseases of various types that affect the acquisition of ocular parameters or interfere with perimetry.
4. Axial length \> 28 mm.
5. Monophthalmia (best-corrected visual acuity of the non-study eye \< 0.01).
6. Coexistence of severe systemic diseases affecting the entire body.
7. Pregnant or lactating women.

   * If both eyes of a patient meet the criteria, the eye with worse visual acuity will be selected for inclusion.

Where it's running

  • Zhongshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.